Study of ALTO-300 in MDD

Clinical trial NCT05922878 · RECRUITING

Trial details

NCT number: NCT05922878
Sponsor: Alto Neuroscience
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2023-06-08
Primary completion: 2026-12-01
Enrollment: 321

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.